Monsanto Co. (MON) to Release Quarterly Earnings on Wednesday
Monsanto Co. (NYSE:MON) will be issuing its Q416 quarterly earnings data on Wednesday, October 5th. Analysts expect the company to announce earnings of ($0.02) per share and revenue of $2.38 billion for the quarter. Investors interested in listening to the company’s conference call can do so using this link.
Shares of Monsanto Co. (NYSE:MON) opened at 102.47 on Tuesday. The company has a 50 day moving average price of $105.05 and a 200 day moving average price of $101.24. Monsanto Co. has a 1-year low of $83.73 and a 1-year high of $114.26. The stock has a market cap of $44.84 billion, a P/E ratio of 45.10 and a beta of 1.19.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 28th. Stockholders of record on Friday, October 7th will be issued a dividend of $0.54 per share. This represents a $2.16 dividend on an annualized basis and a dividend yield of 2.11%. The ex-dividend date is Wednesday, October 5th. Monsanto’s dividend payout ratio (DPR) is presently 89.26%.
In other Monsanto news, CEO Michael K. Stern sold 12,797 shares of the business’s stock in a transaction that occurred on Wednesday, July 13th. The stock was sold at an average price of $101.77, for a total value of $1,302,350.69. Following the sale, the chief executive officer now owns 21,583 shares of the company’s stock, valued at $2,196,501.91. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, COO Brett D. Begemann sold 27,980 shares of the business’s stock in a transaction that occurred on Thursday, July 14th. The shares were sold at an average price of $103.62, for a total value of $2,899,287.60. Following the completion of the sale, the chief operating officer now directly owns 102,480 shares in the company, valued at approximately $10,618,977.60. The disclosure for this sale can be found here. 0.88% of the stock is owned by company insiders.
A number of hedge funds have recently made changes to their positions in MON. WFG Advisors LP raised its stake in shares of Monsanto by 18.6% in the second quarter. WFG Advisors LP now owns 1,009 shares of the company’s stock worth $104,000 after buying an additional 158 shares during the last quarter. Mycio Wealth Partners LLC raised its stake in Monsanto by 1.1% in the second quarter. Mycio Wealth Partners LLC now owns 1,094 shares of the company’s stock worth $113,000 after buying an additional 12 shares in the last quarter. Pinkerton Retirement Specialists LLC raised its stake in Monsanto by 1,179.1% in the second quarter. Pinkerton Retirement Specialists LLC now owns 1,100 shares of the company’s stock worth $114,000 after buying an additional 1,014 shares in the last quarter. Fic Capital Inc. bought a new stake in Monsanto during the second quarter worth $201,000. Finally, Oliver Luxxe Assets LLC bought a new stake in Monsanto during the second quarter worth $206,000. 79.02% of the stock is currently owned by institutional investors.
Several research firms have commented on MON. TheStreet lowered shares of Monsanto from a “buy” rating to a “hold” rating in a report on Monday, September 12th. Citigroup Inc. upped their price target on shares of Monsanto from $112.00 to $116.00 and gave the company a “neutral” rating in a report on Friday, August 19th. BMO Capital Markets set a $128.00 price target on shares of Monsanto and gave the company a “buy” rating in a report on Thursday, September 15th. Credit Agricole SA lowered shares of Monsanto from a “buy” rating to an “underperform” rating and set a $110.00 price target on the stock. in a report on Thursday, September 15th. Finally, Goldman Sachs Group Inc. raised shares of Monsanto from a “sell” rating to a “neutral” rating and set a $104.00 price target on the stock in a report on Tuesday, September 27th. Two analysts have rated the stock with a sell rating, nine have assigned a hold rating, fifteen have given a buy rating and one has given a strong buy rating to the stock. The company presently has an average rating of “Buy” and a consensus target price of $114.21.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Stock Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related stocks with our FREE daily email newsletter.